We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biovail Fires Back At AstraZeneca In Seroquel IP Suit

Law360 (April 6, 2009, 12:00 AM EDT) -- Biovail Corp. has become the latest generics maker to ask a court to invalidate or rule unenforceable two patents for Seroquel XR — AstraZeneca Pharmaceuticals LP's popular treatment for bipolar disorder...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.